This systematic approach clarifies BMP8A/TGF-β1 regulatory mechanisms of BMP8A/TGF-β1 in TD progression while proposing new diagnostic biomarkers and therapeutic targets. This evidence concerns the gene TGFB1 and thanatophoric dysplasia.